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Abstract —Bacteria being used to make anticancer agents could provide an extra source of lead compounds for the pharmaceutical 
industry.  Bacterium Lactobacillus salivarius produce compounds that selectively inhibit growth of human cancer cells Lactobacillus 
salivarius naturally produces a compound called Bacteriocins.  Bacteriocins are bacterial proteins produced to prevent the growth of 
competing microorganisms in a particular biological niche and we can use it as antineoplastic. The aim of this study was to isolate 
bacteriocin produced by lactic acid bacteria. A preparation of bacteriocin from a strain Lactobacillus salivarius has long been shown 
to have antineoplastic activity against a variety of human tumor and animal tumor cell lines in vitro. A total of 60 LAB  were isolated 
from children stool 45 isolate showed a clear antimicrobial activity against indicator strain Streptococcus aureus and by used sodium 
phosphate buffer (pH8) from an 80% ammonium sulfate precipitate. The inhibition  activity was determent by well diffusion assay 
method technique, Bacteriocin purification processes were carried out by using ion-exchange (Trisacryl SP) and gel filtration 
chromatography (Sephacryl – S300). The apparent molecular mass of partially purified bacteriocin was 15. 848 kDa,  Cell Culture 
was maintained in RPMI 1640 medium supplemented with 10% (vol/vol) fetal calf serum,  Cytotoxicity of bacteriocin was assessed on 
human cell line (RD) and animal cell line (MDCK) cell viability after incubation for 48 h in medium containing 500AU/ml (1.15 
mg/ml). Both cell types used in this study were sensitive to bacteriocin and the bacteriocin appeared to inhibit proliferation of tumor 
cell line. The animal cell line was more sensitivity than human cell line. 
   
Keywords—  Lactobacillus salivarius, Bacteriocins, ion-exchange, tumor cell line . 
 
I. INTRODUCTION 
Cancer represents one of the most serious health problems 
worldwide[1] and the improvement of new anticancer 
therapy and more effective treatment strategies are fields of 
utmost importance in drug discovery and clinical therapy [2]. 
A lot of the research in these areas is nowadays focusing on 
cancer-specific mechanisms and the corresponding 
molecular targets (e.g., kinases related to cell cycle 
progression or signal transduction) but the search for 
improved cytotoxic agents (acting on ubiquitous targets such 
as DNA) still represent an important part of new anticancer 
drug innovation (Xiao-Tian  Liang and Wei-Shuo fang 
2006) . Bacteriocins are small peptides (30 –60) amino acid 
with antimicrobial properties against bacteria usually of the 
same or closely related species (narrow spectrum), 
andsometimes against a wide spectrum of species [3], [4],  
 
 
[5], [6], Microorganisms that produce bacteriocins also have 
immunity mechanisms to present self - protection from 
committing “suicide” [7], [8]. 
Cancer, differentiate by uncontrolled growth and spread 
of abnormal cells, due to external and internal factors. 
Environmental factors and chemical carcinogens play a 
predominant role in the induction of DNA lesions and other 
genomic abnormalities [9], Innovation of anticancer drug is 
always an attractive challenge and are classified in different 
ways according to their nature, sources, mechanisms of 
action etc, which may be of microbial products, synthetic 
chemicals, plant or animal extracts [10]. Because of recent 
advances in peptide therapeutic, bacteriocin is presented as a 
therapeutic agent and its biochemical properties have been 
studied, Bacteriocin antineoplastic capability has been 
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insufficiently discovered in the late 1970s by using crude 
bacteriocin preparation toxic to mammalian cells [11], 
purified bacteriocins are obtainable and have shown 
inhibitory properties against different neoplastic line cells, 
Pyocin, colicin, ped-iocin, and microcin are among 
bacteriocins reported to present such activity [12], Moreover, 
modified bacteriocins proved to be effective in a 
glioblastoma xenograft mouse model [11].   
II. MATERIALS AND METHODS  
A. Bacteria in rectal swab samples 
  In total, 60 samples were collected by rectal swabs from 
children in AL-Faluja hospital-Iraq and were kept in sterile 
tubes containing MRS broth media and then inoculated on 
plates of MRS (Man-Rogosa-Sharpe medium) Agar pH 6.2 
(Hi-media, India) and incubated at 37°C aerobically 5% 
CO2 conditions (Gas Pak system) for 48 h, then sub cultured 
on Man-Rogosa-Sharpe medium (MRS) agar for 48 h. The 
growing colonies were characterized by phenotypical 
properties including morphology, gram positive staining and 
absence of catalase, oxidase and motility [13], [14] . 
 
B. Classification of isolates 
  Only isolates of gram-positive rods and catalase negative 
were considered for further identification. Tests for catalase 
were made by adding 5 ml of 3% hydrogen peroxide to the 
cell pellet obtained by centrifuging (12,000 x g for 10 min) 
10 ml of an MRS broth culture. Cultures were considered 
catalase negative if no visible gassing was observed. 
Cultures were examined for growth at 15 °C and 45 °C in 
MRS broth and for gas production by the methods of [15] 
for the latter, 5 ml of 1.5% sterile agar was used as the 
overlay. 
  MRS broth with glucose and beef extract omitted [16] 
was the basal medium used for determination of ammonia 
production from arginine, esculin hydrolysis, and 
carbohydrate fermentations. Esculin hydrolysis and 
ammonia production were determined as described by 
Davis[17]. Ability of cultures to fermentation of 
carbohydrates were determined as described by Schillinger 
and Lücke [18]. The carbohydrates tested were Galactose, 
Glucose, Ribenose, Manitol, Lactose, Xylose and 
Maltose(Merck, Darmstadt, Germany) and sterile water were 
used as negative controls. Cultures of anaerobic organisms 
were incubated in a Gas Pak system . 
 
C. Screening of isolates for antimicrobial activity 
  There are several screening methods available to detect 
antimicrobial activity from supernatants , spot-on-lawn assay 
[19], disc diffusion [20], microtiter plate assay [21], agar 
well diffusion assay [22], multi-well plate assay[23], in this 
studied Antimicrobial activity of Lact.salivarus against 
Staphylococcus aureus was determined by well diffusion 
method under aerobic conditions. Agar plates were 
inoculated with 100 µl of each target microorganism after 
growing them in a broth and diluting appropriately. Wells (5 
mm) were made in the agar and 100 µl of cell-free culture 
supernatant fluid of the isolated strain was placed into each 
well. The inhibition activity against Staphylococcus aureus 
were tested on nutrient agar. Plates were kept at 4°C for 2 h 
and then incubated at 37 °C for 24 h. The antimicrobial 
activity was determined by measuring the diameter of the 
inhibition zone around the wells. The bacterial isolate of 
widest zone of inhibition against the target microorganism 
was selected for further studies. The inhibition activity was 
expressed quantitatively as arbitrary units per milliliter 
(AU/mL). The arbitrary unit (AU) was defined as the 
reciprocal of the highest dilution able to produce a clear zone 
of growth inhibition of the indicator strain. 
 
D. Concentration of the bacteriocin containing 
supernatant by used  Ammonium sulfate precipitation  
  To begin characterization of a new antimicrobial peptide 
is important to decide and to implement a purification 
strategy. Many LAB bacteriocins are not produced in high 
amounts by the producer strain; therefore it is very important 
to concentrate the supernatant that contains the antimicrobial 
substance at the very initial steps. For this purpose, many 
protocols have been implemented ammonium sulfate 
concentration. Isolated strain having maximum antimicrobial 
zone was grown in MRS broth at 37 °C for 24 h. After 
incubation, the broth was centrifuged at (5000 × g for 10 min 
4ºC) and the cells were separated out. Supernatant was used 
as a crude bacteriocin and the peptide fraction precipitated 
from the cell-free supernatant with 80% saturated 
ammonium sulphate [22], After stirring on a magnetic stirrer, 
it was kept undisturbed at 4°C overnight. Precipitates formed 
were collected by centrifugation at 10 000 × g for 10 min 
and re dissolved in 20 mmol sodium phosphate buffer with 
pH=6.0. Inhibition zone of different fractions was recorded 
in comparison with the crude bacteriocin. 
E. Purification of  bacteriocins 
 The crude bacteriocin was precipitated with 80% 
ammonium sulphate  saturation .The methodology described 
above produces a partially purified extract of bacteriocins. 
These extracts must be subjected to other purification step. 
The most frequenly used techniques are Ion Exchange 
Chromatography (IEC) by Trisacryl SP and Gel filtration by 
Sephacryl – S300 . 
 
F.  Determination of protein  
Protein concentration of the bacteriocin in supernatant 
was determined by the method of [23], using bovine serum 
albumin as the standard. 
 
G. Ion Exchange Chromatography: 
    The Ion Exchange chromatography could be used either 
with cation or anion exchange resins that are able to separate 
the peptides by their electric charge at definite pH. Since 
most bacteriocins have positive charges at pH near neutrality, 
the use of cation exchange resins is appropriate for their 
purifications. In this study a standard protocol was used, the 
bacteriocin extract was passed through the cation-exchange 
column, washed with a phosphate buffer containing NaCl at 
concentration of 0.1 to 1.0 M then Trisacryl SP columns was 
packaged with a strong-cation exchange resin (Mega-BE 
SCX, Varian). The flow rate was 0.5 ml/min. Five ml 
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fractions were collected, by using well diffusion methods 
methods antibacterial activity was measured for sensitive 
strain. The extract is stored at -20 ºC . 
 
H. Molecular weight determination in Gel filtration 
Chromatography 
 The molecular weight of the bacteriocin was determined 
by Gel filtration chromatography (Sephacryl – S300) 
chymotrypsinogen A , Bovine serum albumin, Ovalbumine 
and Ribinuclase A was applied to a Sephacryl – S300 
column (2.5 by 40 cm) and equilibrated with 0.05 M 
phosphate buffer (pH 7.0) containing 0.15 M NaCl. The 
column was eluted with this buffered saline. Cells were 
maintained as exponentially growing monolayer's in RPMI 
1640 supplemented with 10% (v/v) FCS (Sigma, Poole, 
United Kingdom). 
 
I. Cytotoxicity Assays  
 The human cell lines (RD)  and animal cell line (MDCK) 
were grown as a monolayer culture in Rosswell Park 
Memorial Institute (RPMI-1640) medium (Sigma, Poole, 
United Kingdom), supplemented with 10% Bovine calf 
serum ( BCS )(GIBCO), 1000 units/ml penicillin, and 100 
mg/ml streptomycin (Life Technologies, Inc., Paisley, 
United Kingdom) [26]. The cultures were maintained at 
37 °C in a humidified 5% CO2 condition. After the 
formation of a monolayer, the cell line was prepared for 
cytotoxicity assay by treating them with trypsin/versine. An 
amount of 0.2 ml of cells suspension was mixed with 0.2ml 
of trypan blue solution and 1.6 ml PBS. Viable cells do not 
stain, whereas dead cells stained with blue color as seen 
under the light microscope[27], The formula found by 
Freshney  was used to calculate the number of cells per 
millimetre[28], 106 (20µl) Cells were seeded in 96-well plate 
then bacteriocin was added 500AU/ml (1.15 mg/ml). Finally, 
cell viability was assesd after incubation for 48 h.  
III. RESULTS 
  Bacteriocin producer strain was isolated from children’s 
Rectal swab in AL-Falluja hospital and the selected strain 
was identified by its physiological and biochemical 
characteristic (Table 1). 
 
Table 1: Physiological an d Biochemical Characteristic 
 
A. Determination of inhibitory spectrum  
The growing of Staphylococcus aureus was inhibited 
(25mm) by using the supernatant of  Lactobacillus salivarius  
to the right side in (Fig.1). The inhibition zone (16.5mm) in 
the middle of (Fig.1) shows the inhibition activity against, 
Staphylococcus aureus, by using purified bacteriocin.  
 
 
 
 
 
 
 
 
 
 
 
 
 
(Fig 1) Bacteriocin activity against Staphylococcus aureus by agar-well 
diffusion method 
B. Purification of bacteriocin 
In the purification step of filtrate culture the proteins were 
concentrated by 80% ammonium sulphate precipitation. The 
recovered proteins were then fractionated by ion-exchange 
chromatography, using Trisacryl SP. All procedures were 
done in cold room. The overall yield and activity are 
summarized in Table 2. 
 
 
 
 
co
in
co
af
ra
co
of
 
 
Table 2: Summary of the purification steps of bacteriocin 
from the culture supernatant of Lact .salivarus 
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Purification 
Stage 
Culture 
supernatant 
Ammonium 
sulphate 
precipitation 
(80% 
saturation 
Trisacryl SP 
chromatography 
Volume (ml) 200 25 40 
Activity (unit 
/ml) 290 456 500 
Total activity 
(AU /ml) 58000 11400 20000 
Total protein 
(mg) 12.5 18.6 1.15 
Speci-fic 
activity 23.2 24.5 434.8 
Purification 1 1.06 18.74 
Recovery (%) 100 19.6 34.5 
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  ent of all types of cell lines with different 
ions of bacteriocin showed highly significant 
effect on growth of the cell lines. All 
ions starting from 18.6 mg/ml of crude bacteriocin 
ment for 48hrs significantly reduced the growth 
D and MDCK cell lines(Table-3) compare to 
up which showed complete confluent monolayer 
e cells (Figure-2,3- a, b,)  
 
 
 
 
 
 
 
 
 
 
 
 
Result 
 
Physiological and biochemical 
characteristic 
Creamy, little sticks and smooth 
and convex colonies 
Colony Morphology 
Gram positive, pleomorphic rod Gram staining 
uniform turbidity Growth in MRS broth 
Homo fermentative Type of fermentation 
Fermentation positive Galactose, Glucose, Ribenose, Manitol, Lactose, Xylose Maltose 
Negative Catalase, Oxidase, Indole 
Negative Nitrate Reduction 
Negative H2S production 
Fermentation positive Gram staining 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure. 2 The effect of Bacteriocin on the growth of  MRCK cell line A= 
control, B=cells treated with 0.575 mg/ml of Bacteriocin. 
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gure. 3 The effect of Bacteriocin of Lact .salivarus on the growth of  RD 
ell line A= control, B=cells treated with 0.575 mg/ml from Bacteriocin 
IV. DISCUSSION 
Bacterial Lactic acid is widely used as antimicrobial and 
ticancer agent. Bacteriocin in this study was extracted by 
l free supernatant method and the crude supernatant was 
essed for its antagonistic activity. The inhibition effect of 
alivirus against Staph.aureus is an indication for 
tibacterial activity and this result matchs several studies 
ich considered bacteriocin as an antibiotic for many 
eases and anticancer [11], [29]. Such activity may be due 
a variety of compounds (fatty acids and peroxides, etc.) 
duced by the antagonistic isolate[30], Moreover, 
cteriocins consist of bactericidal polypeptides with a 
chanism of action similar to that of ionosphere antibiotics 
], The occurrence of bacteriocin production among 
ctobacillus.spp. in competitive, complex microbial 
mmunities suggests that bacteriocins may have a 
ulatory role for population dynamics within bacterial 
systems [32], Our bacterium-derived compound met the 
teria for being considered a bacteriocin. The cytotoxicity 
bacteriocin was investigated on RD and MDCK cell lines 
cancer. The cytotoxicity assay results indicate that 
cteriocins have a cytotoxic effect on neoplastic human and 
imal cell lines. The effect on cells from animal origin is 
re than human origin.  
 The cancer cell line presented different sensibility to 
cteriocin, since MDCK cell lines viability gradually 
creased in number with increasing of bacteriocin 
ncentrations. Bacteriocin was harmless between 0.012 and 
015 mg/ml to RD cell line over 48 h while MRCK cell 
e was harmless in 0.0045 mg/ml this differential 
totoxicity may be related to differences in plasma 
mbrane composition and metabolic activity of target cells. 
].Moreover, 
The difference on the cell surface hydrophobicity may 
luence the effective binding and cytotoxic action. In 
nclusion, Bacteriocins produced by L. salivirus have the 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ratio of Inhibition  Concentration  
of material 
mg/ml 
Bacteriocin 
 
Bacteriocin 
 
Crude 
protein 
 
5.9 0 5.9 
 4.8 0  4.8 
3.0 7.2 3.0 
3.6 14.5 3.6 
0 0 0 
0 0 0 
0 0 0 
0 0 0  
 able-4) The effect of Bacteriocin and Crude protein  on the growth f RD cell lines after 48 hrs in vitro  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ratio of Inhibition 
Concentration  
of material 
mg/ml Bacteriocin 
 
Crude 
protein 
 
25.8 0 0.575 
24.6 13.9 0.288 
19.2   0 0.144 
19.2    7.8 0.072 
6.6    0 0.036 
4.8     0 0.018 
 5.5    0 0.009 
0 0 0.0045 able-3) The effect of Bacteriocin and Crude protein  on the growth 
f MRCK cell lines after 48 hrs in vitro tential to cover a very broad field of application, including 
 medical sector. The ease of bacteriocin extraction  and 
cause it is  safe and non-toxic to humans and animals cells, 
ile it is   lethal to the cancer cells line as complete 
nolayer's is rapidly killed give bacteriocin  chance to be 
nsidered as  anticancer agent. 
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